Concepedia

Roberta Frapolli

RF

61

Publications

4.3K

Citations

33

H-Index

2002

Active since

Affiliations

Mario Negri Institute for Pharmacological Research(Current)

Istituti di Ricovero e Cura a Carattere Scientifico

University of Milan

Fondazione IRCCS Istituto Nazionale dei Tumori

PharmaMar (Spain)

Roberta Frapolli is an author at Mario Negri Institute for Pharmacological Research specializing in medicine, pharmacology, and tumor biology.

Top concepts

MedicinePharmacologyTumor BiologyPathologyCell BiologyTumor MicroenvironmentImmunologyCancer ResearchRadiation OncologyOncology

Publications per year

2002–2023

61

Publications

61

Role of Macrophage Targeting in the Antitumor Activity of Trabectedin

Giovanni Germano, Roberta Frapolli, Cristina Belgiovine et al. · Cancer Cell · 2013 · 847 citations · Full text

Cancer Immunosurveillance, Drug Targeting, Immunology +7

Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth

Giovanni Germano, Simona Lamba, Giuseppe Rospo et al. · Nature · 2017 · 608 citations

Chromatin, Genome Instability, Dna Damage +12

Antitumor and Anti-inflammatory Effects of Trabectedin on Human Myxoid Liposarcoma Cells

Giovanni Germano, Roberta Frapolli, Matteo Simone et al. · Cancer Research · 2010 · 263 citations · Full text

Inflammation, Tumor Biology, Myxoid Liposarcoma +15

Alpha1 acid glycoprotein binds to imatinib (STI571) and substantially alters its pharmacokinetics in chronic myeloid leukemia patients.

Carlo Gambacorti‐Passerini, Massimo Zucchetti, Domenico Russo et al. · PubMed · 2003 · 231 citations

Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models

Cristina Belgiovine, Ezia Bello, Manuela Liguori et al. · British Journal of Cancer · 2017 · 149 citations · Full text

Rows per page

1–5 of 61